Monga mankhwala omwe atha kulepheretsa COVID_19,cepharanthinendiye chinthu chachikulu chogwiritsidwa ntchito kuchokera ku Stephania, mankhwala achi China.
Pa Meyi 10,2022, asayansi aku China adapeza mankhwala a covid_ 19 mankhwala atsopano omwe adapeza ma patent amtundu wadziko.
Izi zitangotuluka, zinali zosangalatsa kwambiri COVID 19 isanathe kuthetsedwa bwino. Mkhalidwe wamakono wa Covid 19. Komanso, malinga ndi malipoti atolankhani, akatswiri ena aku America adasindikizapo kale mapepala asayansi ndikutsimikizira kuti kafukufuku wa cepharanthine ndi wabwino kuposa paxlovid, yemwe wavomerezedwa kuti alembetse.Pakali pano, waku Canada. makampani azamankhwala alumikizana ndi US FDA kuti achite kafukufuku woyesa zamankhwala pamankhwala a COVID-19 ndi Cepharanthine. Tikukhulupirira kuti pakhala kupita patsogolo kwabwino pa R&D ndi kagwiritsidwe ntchito kachipatala ka mankhwalawa posachedwa.
Cepharanthine(CEP) ndi alkaloid yochitika mwachilengedwe yochokera ku Stephania cepharantha Hayata ndipo yawonetsedwa kuti ili ndi anti-yotupa, antioxidative, immunomodulating, antiparasitic, and antiviral properties.
Kuthekera kwake kuchiza ngati antivayirasi sikunakhale kofunikira kwambiri kuposa kulimbana ndi COVID-19 yoyambitsidwa ndi kachilombo koyambitsa matenda amtundu wa 2 (SARS-CoV-2).
Pakati pa eni ake a patent ochepa, tili ndi ma patent okhudzana nawoCepharanthine.
Yunnan Hande Bio-tech Co., Ltd.ndi opanga ndi ogulitsa omwe ali ndi 28+ odziwa zambiri pakuchotsa ndi kulekanitsa zomera.Cepharanthinekuyambira August 2011. Patent yathu ikufotokoza mwatsatanetsatane momwe stephanine imachotsedwa.Ngati mukufuna Cepharanthine pankhaniyi, musazengereze, chonde tithandizeni mwamsanga.
Nthawi yotumiza: May-16-2022